Aurovitas Pharma Polska Sp. z o.o. (Poland)

Aurovitas Pharma Polska Sp. z o.o. is a pharmaceutical company focused on generic medicines, including prescription (Rx) and over-the-counter (OTC) products across 22 therapeutic areas, with a portfolio exceeding 120 products representing roughly 400 dosage forms. Key therapeutic segments highlighted include antibiotics, cardiology, gastroenterology, central nervous system therapies, antiretrovirals and urology, reflecting a broad generics and consumer health scope. The company was established as the third Aurovitas entity in Europe and operates within the Aurobindo Pharma group structure alongside sister companies in Spain and Portugal, with European headquarters located in London. Strategic positioning emphasizes providing high-quality equivalents of established pharmaceuticals (same active substance and therapeutic effect) with competitive pricing, leveraging group-scale development, manufacturing and commercialization capabilities to expand and maintain a multi-therapeutic generic and OTC portfolio.